LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

Clinical trial NCT05879432 · RECRUITING

Trial details

NCT number: NCT05879432
Sponsor: Arch Biopartners Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Kidney Injury Cardiac Surgery

Start date: 2024-03-08
Primary completion: 2027-03-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.